Background: Amiodarone is associated with varying degrees of hepatotoxicity. Aims: to
study the association between the presence of the metabolic syndrome or rightsided heart …

Objectives Amiodarone is a commonly used anti-arrhythmic drug. Hepatotoxicity following
chronic oral administration occurs in 1% to 3% of patients. Hepatotoxicity following …

Amiodarone chlorhydrate is a diiodated benzofuran derivative used to treat cardiac rhythm
abnormalities. Hepatotoxicity is a relatively uncommon side effect of amiodarone and …

The prevalence of apparent amiodarone-related hepatic injury in 104 patients followed
prospectively is compared to that reported in the literature. Asymptomatic elevation of serum …

Background: The prevalence of hepatotoxicity after longterm oral amiodarone therapy in
Chinese patients with or without elevated liver enzymes at baseline is unknown. Hypothesis …

The anti-arrhythmic agent amiodarone (AD) is associated with numerous adverse effects,
but serious liver disease is rare. The improved safety of administration of daily low doses of …

Amiodarone has been reported to cause asymptomatic increases in liver function tests in 15—
55% of patients. Clinically apparent, symptomatic hepatic disease occurs less frequently, but …

Amiodarone is a widely used and effective long-term antiarrhythmic drug but with known
adverse effects. Prolonged oral administration of this drug has been implicated in numerous …

Potential hepatotoxicity related to amiodarone therapy is often a concern when deciding
whether to initiate or continue treatment with this medication. While mostly associated with …

A 63-year-old man presented with ascites after therapy with amiodarone, 200 mg orally once
per day for 22.5 months. A liver biopsy showed grade 3 chronic hepatitis and micronodular …